# Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma

> **NCT00286013** · PHASE2 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 24 (actual)

## Conditions studied

- Locally Advanced and Unresectable, But Non-metastatic Pancreatic Adenocarcinoma or Cholangiocarcinoma

## Interventions

- **DRUG:** Association of gemcitabine, oxaliplatin and radiotherapy

## Key facts

- **NCT ID:** NCT00286013
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05-01
- **Primary completion:** 2006-05-31
- **Final completion:** 2008-07-22
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00286013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00286013, "Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00286013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*